A phase II trial of abiraterone acetate (AA) without prednisone in castration resistant prostate cancer (CRPC) Meeting Abstract


Authors: McKay, R. R.; Werner, L.; Jones, A.; Choudhury, A. D.; Pomerantz, M.; Sweeney, C.; Bubley, G. J.; Slovin, S. F.; Morris, M. J.; Kantoff, P. W.; Taplin, M. E.
Abstract Title: A phase II trial of abiraterone acetate (AA) without prednisone in castration resistant prostate cancer (CRPC)
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 272s
Language: English
ACCESSION: WOS:000411931703030
DOI: 10.1200/JCO.2017.35.15_suppl.5040
PROVIDER: wos
Notes: Meeting Abstract: 5040 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Susan Slovin
    254 Slovin
  2. Michael Morris
    577 Morris
  3. Philip Wayne Kantoff
    197 Kantoff